Polar Capital Holdings Plc
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1837309
London, X0
Position in TEVA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$176,607,936
+$20,735,190 QoQ
Shares Held
5,212,749
+0.7% QoQ
Ownership
0.447%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#25
of 674 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Polar Capital Holdings Plc holds $202,891,087 across 2 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (87.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
5,212,749 | $176,607,936 | |
| 2 | BIOA |
BioAge Labs, Inc.
|
1,072,344 | $26,283,151 |
All Filings in TEVA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $176,607,936 | 5,212,749 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $155,872,746 | 5,175,058 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $155,665,804 | 4,987,690 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $80,983,456 | 4,009,082 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||